416 related articles for article (PubMed ID: 9415189)
1. Virus vector design in gene therapy.
Günzburg WH; Salmons B
Mol Med Today; 1995 Dec; 1(9):410-7. PubMed ID: 9415189
[TBL] [Abstract][Full Text] [Related]
2. Viral vectors for gene transfer: a review of their use in the treatment of human diseases.
Walther W; Stein U
Drugs; 2000 Aug; 60(2):249-71. PubMed ID: 10983732
[TBL] [Abstract][Full Text] [Related]
3. [Gene therapy: new developments].
Mohr L; Geissler M
Praxis (Bern 1994); 2002 Dec; 91(51-52):2227-35. PubMed ID: 12564039
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus as an integrating vector.
Mitani K; Kubo S
Curr Gene Ther; 2002 May; 2(2):135-44. PubMed ID: 12109211
[TBL] [Abstract][Full Text] [Related]
5. Latest development in viral vectors for gene therapy.
Lundstrom K
Trends Biotechnol; 2003 Mar; 21(3):117-22. PubMed ID: 12628368
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus and adeno-associated virus mediated gene transfer.
Kremer EJ; Perricaudet M
Br Med Bull; 1995 Jan; 51(1):31-44. PubMed ID: 7767647
[TBL] [Abstract][Full Text] [Related]
7. Virus-mediated gene transfer for cutaneous gene therapy.
Ghazizadeh S; Taichman LB
Hum Gene Ther; 2000 Nov; 11(16):2247-51. PubMed ID: 11084682
[TBL] [Abstract][Full Text] [Related]
8. Viral vectors for gene therapy.
Robbins PD; Tahara H; Ghivizzani SC
Trends Biotechnol; 1998 Jan; 16(1):35-40. PubMed ID: 9470229
[TBL] [Abstract][Full Text] [Related]
9. Viral vectors for gene delivery and gene therapy within the endocrine system.
Stone D; David A; Bolognani F; Lowenstein PR; Castro MG
J Endocrinol; 2000 Feb; 164(2):103-18. PubMed ID: 10657846
[TBL] [Abstract][Full Text] [Related]
10. Viral vectors in gene therapy.
Smith AE
Annu Rev Microbiol; 1995; 49():807-38. PubMed ID: 8561480
[TBL] [Abstract][Full Text] [Related]
11. Production of viral vectors for gene therapy applications.
Wu N; Ataai MM
Curr Opin Biotechnol; 2000 Apr; 11(2):205-8. PubMed ID: 10753765
[TBL] [Abstract][Full Text] [Related]
12. Viral vector systems for gene therapy.
Jolly D
Cancer Gene Ther; 1994 Mar; 1(1):51-64. PubMed ID: 7621239
[No Abstract] [Full Text] [Related]
13. AAV6 Vector Production and Purification for Muscle Gene Therapy.
Halbert CL; Allen JM; Chamberlain JS
Methods Mol Biol; 2018; 1687():257-266. PubMed ID: 29067669
[TBL] [Abstract][Full Text] [Related]
14. Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions.
Lowenstein PR; Mandel RJ; Xiong WD; Kroeger K; Castro MG
Curr Gene Ther; 2007 Oct; 7(5):347-60. PubMed ID: 17979681
[TBL] [Abstract][Full Text] [Related]
15. Viral vectors for gene delivery to the central nervous system.
Lentz TB; Gray SJ; Samulski RJ
Neurobiol Dis; 2012 Nov; 48(2):179-88. PubMed ID: 22001604
[TBL] [Abstract][Full Text] [Related]
16. Production of clinical-grade recombinant adeno-associated virus vectors.
Snyder RO; Flotte TR
Curr Opin Biotechnol; 2002 Oct; 13(5):418-23. PubMed ID: 12459331
[TBL] [Abstract][Full Text] [Related]
17. Development of hybrid viral vectors for gene therapy.
Huang S; Kamihira M
Biotechnol Adv; 2013; 31(2):208-23. PubMed ID: 23070017
[TBL] [Abstract][Full Text] [Related]
18. Improvements in gene therapy: averting the immune response to adenoviral vectors.
Ritter T; Lehmann M; Volk HD
BioDrugs; 2002; 16(1):3-10. PubMed ID: 11908997
[TBL] [Abstract][Full Text] [Related]
19. Viral Vector-Based Gene Therapy.
Li X; Le Y; Zhang Z; Nian X; Liu B; Yang X
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175441
[TBL] [Abstract][Full Text] [Related]
20. Progresses towards safe and efficient gene therapy vectors.
Chira S; Jackson CS; Oprea I; Ozturk F; Pepper MS; Diaconu I; Braicu C; Raduly LZ; Calin GA; Berindan-Neagoe I
Oncotarget; 2015 Oct; 6(31):30675-703. PubMed ID: 26362400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
